Raymond Rowan, DPM
Foot & Ankle Surgery · Palm City, FLNPI 1306188636
Payments from drug & device makers
Across 112 payments — averaging $89.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Orthofix Medical, Inc.$1K
- Paragon 28, Inc.$1K
- Southern Edge Orthopaedics, Inc.$772
- Stryker$664
- DJO, LLC$434
- plus $3K from 19 others
What the payments were for
- Royalty or licence$120%
- Travel & lodging$2,74227%
- Food & beverage$3,94639%
- Education$3,17232%
- Gifts$1652%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 14 | $2,912 |
| Orthofix Medical, Inc. | 9 | $1,362 |
| Paragon 28, Inc. | 3 | $1,323 |
| Southern Edge Orthopaedics, Inc. | 1 | $772 |
| Stryker | 25 | $664 |
| DJO, LLC | 9 | $434 |
| Amniox Medical, Inc. | 6 | $434 |
| Exactech, Inc. | 3 | $363 |
| Life Spine, Inc. | 4 | $301 |
| Biotissue Holdings Inc. | 2 | $291 |
| Abbott | 3 | $178 |
| Smith+Nephew | 10 | $176 |
| Amgen | 4 | $176 |
| Crossroads Extremity Systems, LLC | 2 | $157 |
| Acera Surgical, Inc. | 2 | $135 |
| Novastep Inc. | 1 | $112 |
| Organogenesis Inc. | 5 | $84 |
| Next Science LLC | 2 | $31 |
| Integra Lifesciences Corporation | 1 | $24 |
| Averitas Pharma Inc. | 1 | $24 |
| AbbVie | 1 | $22 |
| Embody, Inc. | 1 | $18 |
| Reel Surgical, Inc. | 1 | $17 |
| Arthrosurface Incorporated | 1 | $17 |
| Kerecis Limited | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,323
- TrueLok$1,142
- Prokera$278
- AmnioGraft$278
- AmnioGuard$278
- NEOX$273
- CLARIX$273
- VANTAGE$263
- ALLOPURE$153
- Supera peripheral stent system$133
- CMF$124
- Restrata Wound Matrix$122
- KRYSTEXXA$114
- CENTROLOCK MIS Bunion Correction$112
- NOVATION HIP$100
How this compares
$10,037 in reported general payments places this provider in the 75th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 25 | $1,504 |
| Ketoconazole | 66 | $1,487 |
| Cephalexin | 108 | $977 |
| Terbinafine Hcl | 55 | $378 |
| Meloxicam | 120 | $308 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $301 |
| Gabapentin | 30 | $266 |
| Mupirocin | 32 | $202 |
| Clindamycin Hcl | 19 | $188 |
| Colchicine | 12 | $154 |
| Doxycycline Hyclate | 24 | $129 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $100 |
| Triamcinolone Acetonide | 13 | $95 |
| Ibuprofen | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Palm City
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
- Christopher ReevesLake Mary$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.